Wixela Inhub vs. Airduo Digihaler

Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) and Airduo Digihaler (fluticasone propionate and salmeterol) both contains a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) used for twice-daily treatment of asthma in patients aged 4 years and older or maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).

Wixela Inhub is used to treat asthma in patients aged 4 years and older or for maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).

Airduo Digihaler is used to treat asthma in patients aged 12 years and older.

Side effects of Wixela Inhub and Airduo Digihaler that are similar include oral thrush, cough, and headaches.

Side effects of Wixela Inhub that are different from Airduo Digihaler include upper respiratory tract infection or inflammation, sore throat, hoarseness, bronchitis, nausea, vomiting, pneumonia, and musculoskeletal pain.

Side effects of Airduo Digihaler that are different from Wixela Inhub include stuffy or runny nose and back pain.

Both Wixela Inhub and may interact with antivirals, azole antifungals, clarithromycin, telithromycin, nefazodone, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics.

Wixela Inhub may also interact with other medicines containing a LABA.

Common side effects of Wixela Inhub include:

• upper respiratory tract infection or inflammation,
• sore throat,
• hoarseness,
• oral thrush,
• bronchitis,
• cough,
• headaches,
• nausea and vomiting,
• pneumonia,
• viral respiratory infections, and
• musculoskeletal pain

Common side effects of Airduo Digihaler include:

• stuffy or runny nose,
• oral thrush,
• headache,
• cough, and
• back pain

Wixela Inhub (fluticasone propionate and salmeterol inhalation powder) contains a combination of a corticosteroid and a long-acting beta-adrenergic agonist (LABA) indicated for twice-daily treatment of asthma in patients aged 4 years and older or maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD). Wixela Inhub is available in generic form.

Airduo Digihaler (fluticasone propionate and salmeterol) is a combination of a corticosteroid and a long-acting beta2-adrenergic agonist (LABA) indicated for treatment of asthma in patients aged 12years and older. AirDuo Digihaler should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta2-adrenergic agonist (LABA).

Wixela Inhub may interact with additional medicines containing a LABA, ritonavir, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Wixela Inhub; it is unknown how it would affect a fetus. It is unknown if Wixela Inhub passes into breast milk. Consult your doctor before breastfeeding.

Airduo Digihaler may interact with ritonavir, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, saquinavir, telithromycin, monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants, beta-blockers, and diuretics. Tell your doctor all medications and supplements you use.

The dose of Wixela Inhub for treatment of asthma in patients aged 12 years and older is 1 inhalation of Wixela Inhub 100/50, Wixela Inhub 250/50, or Wixela Inhub 500/50 twice daily. The dose of Wixela Inhub for treatment of asthma in patients aged 4 to 11 years is 1 inhalation of Wixela Inhub 100/50 twice daily. The dose of Wixela Inhub for maintenance treatment of COPD is 1 inhalation of Wixela Inhub 250/50 twice daily.

The dose of Airduo Digihaler is 1 inhalation of AirDuo Digihaler 55/14 mcg, 113/14 mcg, or 232/14 mcg twice daily.